← Leaderboards
Talmadge E King
National Jewish Health
$1,393,645
Attributed
$1,393,645
Total exposure
2
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $191.2K · FY2005–09$200K$150K$100K$50K$0
'05
'06
'07
'08
'09
Funding mix
By agency
NIH$1,393,645 · 2
By mechanism
U10$935,841 · 1
P50$457,804 · 1
Top collaborators
No co-investigators on record.
Most similar at National Jewish Health
Same institution · by research overlap
- Lisa A Maier$11,952,941
- Ivana V Yang$13,155,768
- Brian J Day$12,321,853
- Diane Sullivan$3,882,412
- Shaodong Dai$4,912,737
Others in their field
Top investigators on “Clinical Research”
- David Heimbrook · Leidos Biomedical Research, Inc.$1,040,569,537
- Leonard Freedman · Leidos Biomedical Research, Inc.$975,089,882
- Lawrence Corey · Fred Hutchinson Cancer Center$739,766,552
- Sonia M Thomas · Research Triangle Institute$700,865,642
- Jeffrey P Krischer · University Of South Florida$611,867,176
- Barton F Haynes · Duke University$538,862,577
Research focus
Clinical ResearchInflammationClinical TrialsWound HealingCytokineMultidisciplinaryMedicalNewly DiagnosedFibrosisDiagnosisInterferon Type IiAzathioprineBaseMulticenter TrialsHamman-Rich SyndromeClinical TreatmentCommunitiesCessation Of LifeAbstractingDesignDouble-Blind MethodEtiologyInterferon Gamma 1bConduct Clinical Trials
Grant awards (7)
Idiopathic Pulmonary Fibrosis Clinical Research Network$191,220
U10 · FY2009 · HL · contact PI
Idiopathic Pulmonary Fibrosis Clinical Research Network$183,907
U10 · FY2008 · HL · contact PI
Idiopathic Pulmonary Fibrosis Clinical Research Network$183,520
U10 · FY2007 · HL · contact PI
Idiopathic Pulmonary Fibrosis Clinical Research Network$187,819
U10 · FY2006 · HL · contact PI
Idiopathic Pulmonary Fibrosis Clinical Research Network$189,375
U10 · FY2005 · HL
ROLE OF IFN GAMMA AND KGF IN HUMAN PULMONARY FIBROSIS$208,827
P50 · FY2001 · HL
ROLE OF IFN GAMMA AND KGF IN HUMAN PULMONARY FIBROSIS$248,977
P50 · FY2000 · HL